US FDA authorises blood plasma to treat Covid-19
The Trump administration is also reportedly planning to fast-track vaccine developed in Britain
23 August 2020 - 23:42
Washington — The Trump administration authorised emergency approval of a new coronavirus therapeutic treatment and is reportedly considering fast-tracking a vaccine developed in Britain, the day before the start of the Republican National Convention.
The US Food & Drug Administration (FDA) on Sunday said it had authorised the use of blood plasma from patients who have recovered from Covid-19 as a treatment for the disease. The treatment had been given to more than 70,000 patients, the Washington Post reported, citing officials familiar with the decision...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.